Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint

DOI10.1080/03610910902903125zbMath1167.62069OpenAlexW2098460890MaRDI QIDQ3391873

Atanu Biswas, Pinakpani Pal

Publication date: 13 August 2009

Published in: Communications in Statistics - Simulation and Computation (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/03610910902903125

zbMATH Keywords

minimizationgroup sequential designsconstraintsethical allocation

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Optimal statistical designs (62K05) Sequential statistical design (62L05) Computer aspects of numerical algorithms (65Y99)

Related Items (1)

Unbalanced and Partial Group Sequential Methods for Normal Responses in Clinical Trials

Cites Work

• Unnamed Item
• Optimal Adaptive Designs for Binary Response Trials
• Response adaptive designs that incorporate switching costs and constraints
• The generalized Polya's urn design for sequential medical trials
• Asymptotic inference with response-adaptive treatment allocation designs
• A play-the-winner-type urn design with reduced variability
• An adaptive allocation for continuous response using Wilcoxon-Mann-Whitney score
• A program for sequential allocation of three Bernoulli populations
• Adaptive designs for normal responses with prognostic factors
• Two-population sequential tests with three hypotheses
• Response‐Adaptive Randomization for Clinical Trials with Continuous Outcomes
• Adaptive and nonadaptive group sequential tests
• Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses

This page was built for publication: Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint